Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Epigenetics ; 12(1): 87, 2020 06 17.
Article in English | MEDLINE | ID: mdl-32552862

ABSTRACT

BACKGROUND: Cancer subtype switching, which involves unclear cancer cell origin, cell fate decision, and transdifferentiation of cells within a confined tumor microenvironment, remains a major problem in pancreatic cancer (PDA). RESULTS: By analyzing PDA subtypes in The Cancer Genome Atlas, we identified that epigenetic silencing of apoptosis-associated tyrosine kinase (AATK) inversely was correlated with mRNA expression and was enriched in the quasi-mesenchymal cancer subtype. By comparing early mouse pancreatic lesions, the non-invasive regions showed AATK co-expression in cells with acinar-to-ductal metaplasia, nuclear VAV1 localization, and cell cycle suppression; but the invasive lesions conversely revealed diminished AATK expression in those with poorly differentiated histology, cytosolic VAV1 localization, and co-expression of p63 and HNF1α. Transiently activated AATK initiates acinar differentiation into a ductal cell fate to establish apical-basal polarization in acinar-to-ductal metaplasia. Silenced AATK and ectopically expressed p63 and HNF1α allow the proliferation of ductal PanINs in mice. CONCLUSION: Epigenetic silencing of AATK regulates the cellular transdifferentiation, proliferation, and cell cycle progression in converting PDA-subtypes.


Subject(s)
Apoptosis Regulatory Proteins/genetics , Epigenesis, Genetic/genetics , Metaplasia/genetics , Pancreatic Neoplasms/genetics , Protein-Tyrosine Kinases/genetics , Aged , Animals , Cell Differentiation , DNA Methylation/genetics , Disease Models, Animal , Female , Gene Silencing , Hepatocyte Nuclear Factor 1-alpha/genetics , Humans , Metaplasia/diagnosis , Mice , Middle Aged , Pancreatic Neoplasms/pathology , Pregnancy , Proto-Oncogene Proteins c-vav/genetics , RNA, Messenger/genetics , Trans-Activators/genetics , Tumor Microenvironment/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...